دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Adding Salt to Foods and Risk of Cardiovascular Disease
Hao Ma, MD, PH D, a Xuan Wang, MD, P HD, a Xiang Li, MD, PHD, a Yoriko Heianza, RD, P HD, a Lu Qi, MD, P HD
doi : 10.1016/j.jacc.2022.09.039
Volume 80, Issue 23, 6 December 2022, Pages 2157-2167
We recently found that the frequency of adding salt to foods could reflect a person’s long-term salt taste preference and sodium intake, and was significantly related to life expectancy.
Dietary Salt Intake Preferences and the Risk of Cardiovascular Disease∗
Sara Ghoneim, MD
doi : 10.1016/j.jacc.2022.10.005
Volume 80, Issue 23, 6 December 2022, Pages 2168-2170
2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Annular Calcification, Rings, and Bioprostheses
Mackram F. Eleid, MD, a Dee Dee Wang, MD,b Amit Pursnani, MD,c Susheel K. Kodali, MD, d Issac George, MD, e Igor Palacios, MD, f Hyde Russell, MD,g Raj R. Makkar, MD, h Saibal Kar, MD, i Lowell F. Satler, MD,j Vivek Rajagopal, MD, k George Dangas, MD, l Gilbert H.L. Tang, MD, MSC , MBA, m James M. McCabe, MD,n Brian K. Whisenant, MD, o Kenith Fang, MD, p Tatiana Kaptzan, PHD, q Bradley Lewis, MS,r Pamela Douglas, MD, s Rebecca Hahn, MD,d Jeremy Thaden, MD,a Jae K. Oh, MD, a Martin Leon, MD,d William O’Neill, MD,b Charanjit S. Rihal, MD, MBA, a Mayra E. Guerrero, MD
doi : 10.1016/j.jacc.2022.09.037
Volume 80, Issue 23, 6 December 2022, Pages 2171-2183
The MITRAL (Mitral Implantation of Transcatheter Valves) trial is the first prospective study for valve-in-mitral annular calcification (ViMAC), mitral valve-in-ring (MViR), and mitral valve-in-valve (MViV) using balloon-expandable aortic transcatheter heart valves. Procedural outcomes beyond 1 year are not well described.
Percutaneous Mitral Valve Replacement: The Drum Beats on and Louder∗
R. Jay Widmer, MD, PHD, a Molly Szerlip, MD
doi : 10.1016/j.jacc.2022.10.014
Volume 80, Issue 23, 6 December 2022, Pages 2184-2186
Ultrasonic Texture Features for Assessing Cardiac Remodeling and Dysfunction
Quincy A. Hathaway, PHD, a, * Naveena Yanamala, PHD, b, * Nanda K. Siva, BS, a Donald A. Adjeroh, PHD, c John M. Hollander, P HD, d Partho P. Sengupta, MD, DM
doi : 10.1016/j.jacc.2022.09.036
Volume 80, Issue 23, 6 December 2022, Pages 2187-2201
Changes in cardiac size, myocardial mass, cardiomyocyte appearance, and, ultimately, the function of the entire organ are interrelated features of cardiac remodeling that profoundly affect patient outcomes.
Assessment of Myocardial Texture: The Next Frontier in Echocardiographic Quantification∗
Thomas H. Marwick, MBBS, PH D, MPH
doi : 10.1016/j.jacc.2022.10.003
Volume 80, Issue 23, 6 December 2022, Pages 2202-2204
Enhanced Mitochondrial Calcium Uptake Suppresses Atrial Fibrillation Associated With Metabolic Syndrome
Lucile Fossier, PHD, a, * Mathieu Panel, PHARMD, PH D, a, * Laura Butruille, PHD, b Sarah Colombani, PH D, a Lan Azria, MS C,a Eloise Woitrain, E NG ,b Raphael Decoin, P HARMD, b Angelo G. Torrente, P HD, c Jérôme Thireau, PH D, a Alain Lacampagne, P HD, a David Montaigne, MD, PHD, b Jérémy Fauconnier, PH D
doi : 10.1016/j.jacc.2022.09.041
Volume 80, Issue 23, 6 December 2022, Pages 2205-2219
Patients with metabolic syndrome (MetS) have an increased risk of atrial fibrillation (AF). Impaired Ca2+ homeostasis and mitochondrial dysfunction have emerged as an arrhythmogenic substrate in both patients and animal models of MetS. Whether impaired mitochondrial Ca2+ handling underlies AF associated with MetS remains poorly explored.
Targeting Mitochondrial Calcium Handling to Treat Atrial Fibrillation∗
Niels Voigt, MD, a,b,c Christoph Maack, MD,d Julius Ryan D. Pronto, MSC
doi : 10.1016/j.jacc.2022.09.043
Volume 80, Issue 23, 6 December 2022, Pages 2220-2223
Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review
Jeremy P. Moore, MD, MS, a,b,c Ariane Marelli, MD, PHD, d Luke J. Burchill, MBBS, PH D, e,f Henry Chubb, MA, MBBS, PHD, g S. Lucy Roche, MBC H B,h Ari M. Cedars, MD, i Paul Khairy, MD, PH D, j Ali N. Zaidi, MD, k Jan Janousek, MD, PH D, l David S. Crossland, MBC H B, MRCPCH,m Robert H. Pass, MD,n Jeffrey P. Jacobs, MD, o Jonathan N. Menachem, MD, p David S. Frankel, MD, q Sabine Ernst, MD, PH D, r Jim T. Vehmeijer, MD, PH D, s Mitchell I. Cohen, MD
doi : 10.1016/j.jacc.2022.09.038
Volume 80, Issue 23, 6 December 2022, Pages 2224-2238
Together, heart failure and arrhythmia represent the most important cardiovascular sources of morbidity and mortality among adults with congenital heart disease (ACHDs).
Pediatric and Congenital Cardiovascular Disease Research Challenges and Opportunities: JACC Review Topic of the Week
Alexander R. Opotowsky, MD, MMSC ,a Kiona Y. Allen, MD,b Emily M. Bucholz, MD, PHD, MPH, c Kristin M. Burns, MD,d Pedro del Nido, MD, e Kathleen N. Fenton, MD, d Bruce D. Gelb, MD, f James N. Kirkpatrick, MD,g Shelby Kutty, MD,h Linda M. Lambert, APRN, i Keila N. Lopez, MD, MPH,j Laura J. Olivieri, MD, k Nathan M. Pajor, MD, MS, l Sara K. Pasquali, MD, m Christopher J. Petit, MD,n Erica Sood, P HD, o John M. VanBuren, PHD, p Gail D. Pearson, MD, SC D, d Shelley D. Miyamoto, MD
doi : 10.1016/j.jacc.2022.09.032
Volume 80, Issue 23, 6 December 2022, Pages 2239-2250
The National Heart, Lung, and Blood Institute convened a workshop in August 2021 to identify opportunities in pediatric and congenital cardiovascular research that would improve outcomes for individuals with congenital heart disease across the lifespan.
A New Era of Lay Rescuer CPR Training: An Interactive Approach for Engaging High Schoolers
Lorrel E.B. Toft, MD Jamaal Richie, MD John M. Wright, MDAlok Amraotkar, MD Praneeth Katrapati, MD Sara Fulmer, PhD Katie N. Dainty, PhD Sumeet S. Chugh, MD Henry Halperin, MD, MA
doi : 10.1016/j.jacc.2022.09.040
Volume 80, Issue 23, 6 December 2022, Pages 2251-2253
Another Road to Rome: Ischemic Mitral Regurgitation
Xuan Jiang, MD, PhD Jinduo Liu, MD, PhD *Tianxiang Gu, MD, PhD
doi : 10.1016/j.jacc.2022.08.810
Volume 80, Issue 23, 6 December 2022, Pages e213-e214
Reply: Another Road to Rome: Ischemic Mitral Regurgitation
Ons Marsit, PhD Robert A. Levine, MD *Jonathan Beaudoin, MD
doi : 10.1016/j.jacc.2022.09.042
Volume 80, Issue 23, 6 December 2022, Page e215
